Department of Nuclear Medicine, Capital Medical University Affiliated Beijing Anzhen Hospital, No. 2 Anzhen Road, Chaoyang District, Beijing, 100029, China,
Ann Nucl Med. 2014 Feb;28(2):88-93. doi: 10.1007/s12149-013-0790-9. Epub 2013 Dec 17.
Combination of both morphological and functional information has gained more and more appreciation with the concept of "functionally relevant coronary artery lesion (FRCAL)" and "functional revascularization". This has paved the way for non-invasive single-photon emission computed tomography (SPECT)/computed tomography angiography (CTA) hybrid imaging. We aimed at assessing the value of cardiac hybrid imaging on the detection of FRCAL and its potential as a gatekeeper for invasive examination and treatment.
In Two hundred and thirty-eight patients with known or suspected coronary artery disease (CAD) underwent CTA and myocardial perfusion imaging (MPI) using SPECT on a dual system scanner in one session before treatment. 78 patients underwent invasive coronary angiography (CAG) within 1 month. Detection of FRCAL by the combination of SPECT/CTA was compared with SPECT/CAG, which served as a standard of reference. According to the both combination results, treatment decision (revascularization or medical treatment) was chosen in the catheterization laboratory.
Sensitivity, specificity, accuracy, positive and negative prediction rate by SPECT/CTA vs. SPECT/CAG for the detection of flow-limiting coronary stenosis on patient- and vessel-based analysis were 94.33, 72.00, 87.18, 87.71, 85.71 % and 88.71, 92.44, 91.45, 80.89, 95.78 %, respectively. No revascularization procedures were performed in patients without flow-limiting stenosis. However, more than one-third (25/67, 37 %) of revascularized vessels were not associated with ischemia on MPI.
The cardiac SPECT/CTA hybrid imaging can accurately detect FRCAL and thereby it may be used as a gatekeeper for CAG and revascularization procedures.
形态学和功能信息的结合随着“功能相关冠状动脉病变(FRCAL)”和“功能血运重建”概念的出现而受到越来越多的关注。这为非侵入性单光子发射计算机断层扫描(SPECT)/计算机断层血管造影(CTA)混合成像铺平了道路。我们旨在评估心脏混合成像在检测 FRCAL 中的价值及其作为有创检查和治疗的“守门员”的潜力。
在一项研究中,238 例已知或疑似冠心病(CAD)患者在一次治疗前在双系统扫描仪上同时进行 CTA 和 SPECT 心肌灌注成像(MPI)。78 例患者在 1 个月内行有创冠状动脉造影(CAG)。SPECT/CTA 结合检测 FRCAL 的结果与 SPECT/CAG 进行比较,后者作为参考标准。根据两种组合的结果,在导管室选择治疗决策(血运重建或药物治疗)。
在患者和血管基础上的分析中,SPECT/CTA 对 FRCAL 的检测在患者和血管基础上的敏感性、特异性、准确性、阳性预测率和阴性预测率分别为 94.33%、72.00%、87.18%、87.71%和 85.71%和 88.71%、92.44%、91.45%、80.89%、95.78%。没有血流限制狭窄的患者不进行血运重建。然而,超过三分之一(25/67,37%)的血运重建血管与 MPI 上的缺血无关。
心脏 SPECT/CTA 混合成像可以准确地检测 FRCAL,因此它可以作为 CAG 和血运重建的“守门员”。